Understanding Tofersen’s Impact on SOD1 ALS, Neurofilament Light скачать в хорошем качестве

Understanding Tofersen’s Impact on SOD1 ALS, Neurofilament Light

At the 2022 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting, principal investigator Timothy Miller, MD, PhD, presented additional data from VALOR and its OLE. Specifically, he discussed tofersen’s impact on SOD1 protein and neurofilament light, as well as the need to initiate treatment as early as possible after ALS diagnosis. (https://www.neurologylive.com/view/un...) More content: Timothy Miller, MD, PhD, on the Impact of Tofersen (https://www.neurologylive.com/view/cr...) Critical Takeaways, Learning Experiences From the Tofersen Trials (https://www.neurologylive.com/view/ne...)